Company
BioIntelliSense
Also known as BioIntelliSense, Inc
- Business model
- B2B
- Legal name
- BioIntelliSense, Inc
Claim, correct or request removal
Record updated 29 September 2026
About
Early Detection Made Simple. The BioButton system delivers scalable continuous monitoring that proactively identifies early signs of patient deterioration. View our solutions.
Funding snapshot
- Total raised
- $140MSEC form D sum, as of 2026-09-29Source (opens in a new tab)
- Latest round
- Round, $58.3M2025-12-04
Funding rounds
- Round, 2025
- $58.3M2025-12-04, SEC form D sold, 14 investors
- Round, 2021
- $45M2021-04-07, SEC form D sold, 16 investors
- Round, 2020
- $12M2020-08-20, SEC form D sold, 11 investors
- Round, 2018
- $25M2018-12-14, SEC form D sold, 22 investors
Loading relationship preview